You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Thrombocythemia, Essential

Showing 51 - 75 of 4,778
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thrombocythemia, Hemorrhagic Trial in Worldwide (Anagrelide, Hydroxyurea)

Completed
Has Results
  • Thrombocythemia, Hemorrhagic
  • Pleven, Bulgaria
  • +14 more
May 13, 2021

Myelofibrosis Transformation in Essential Thrombocythemia, Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary

Recruiting
  • Myelofibrosis Transformation in Essential Thrombocythemia
  • +2 more
  • Elotuzumab
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Feb 17, 2021

Myelofibrosis Trial in Canton (Jaktinib Hydrochloride Tablet)

Recruiting
  • Myelofibrosis
  • Jaktinib Hydrochloride Tablet
  • Canton, Ohio
    Site 01
Aug 18, 2022

Primary Myelofibrosis, Polycythemia Vera, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide (RO7490677,

Completed
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Phoenix, Arizona
  • +22 more
Dec 7, 2021

Primary Myelofibrosis (PMF), Post Polycythemia Myelofibrosis (PPV MF), Thrombocythemia Myelofibrosis (PET-MF) Trial

Available
  • Primary Myelofibrosis (PMF)
  • +2 more
  • (no location specified)
Jan 18, 2022

Study (MOST)

Completed
  • MPN (Myeloproliferative Neoplasms)
    • Huntsville, Alabama
    • +115 more
    May 11, 2022

    Primary Myelofibrosis (PMF), Post-polycythemia Vera (Post-PV) Myelofibrosis, Postessential Thrombocythemia (Post-ET)

    Completed
    Has Results
    • Primary Myelofibrosis (PMF)
    • +2 more
    • Phoenix, Arizona
    • +12 more
    Jan 12, 2021

    Essential Thrombocythemia, Primary Myelofibrosis, Fibrotic Stage, Primary Myelofibrosis, Prefibrotic Stage Trial in Doha

    Unknown status
    • Essential Thrombocythemia
    • +2 more
    • Diagnostic (18F-FLT PET/CT)
    • Doha, Qatar
      National Center for Cancer Care & Research (NCCCR)
    Sep 27, 2020

    Myelofibrosis, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Tumor Overlap Syndrome Trial in Worldwide

    Recruiting
    • Myelofibrosis
    • +5 more
    • Birmingham, Alabama
    • +27 more
    Oct 17, 2022

    Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post- Essential Thrombocythemia Myelofibrosis Trial in Worldwide

    Completed
    Has Results
    • Primary Myelofibrosis
    • +2 more
    • Phoenix, Arizona
    • +61 more
    May 5, 2022

    Xagrid (FOX) Study In Adult Essential Thrombocythemia

    Completed
    Has Results
    • Essential Thrombocythemia
      • Paris, Cedex 13, France
      • +45 more
      Jun 7, 2021

      Myelofibrosis Trial in Stanford, Ann Arbor (Idelalisib, Ruxolitinib)

      Terminated
      Has Results
      • Myelofibrosis
      • Stanford, California
      • +1 more
      Aug 31, 2020

      Essential Thrombocythemia Trial in Worldwide (Ropeginterferon alfa-2b, Anagrelide)

      Recruiting
      • Essential Thrombocythemia
      • Phoenix, Arizona
      • +60 more
      Dec 30, 2021

      Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV-MF), Post-Essential Thrombocythemia Myelofibrosis

      Recruiting
      • Primary Myelofibrosis (PMF)
      • +2 more
      • Glendale, California
      • +28 more
      May 5, 2022

      Primary Myelofibrosis Trial (Pacritinib)

      Withdrawn
      • Primary Myelofibrosis
      • Pacritinib
      • (no location specified)
      May 3, 2021

      Endoplasmic Reticulum Stress and Resistance to Treatments in

      Completed
      • Polycythemia Vera
      • Essential Thrombocythemia
      • RNA sample of total leukocytes before start of treatment
      • Angers, France
      • +6 more
      Jun 18, 2020

      Myelofibrosis Trial in United States (Simtuzumab, Ruxolitinib)

      Completed
      Has Results
      • Myelofibrosis
      • Scottsdale, Arizona
      • +6 more
      Jun 17, 2020

      Polycythemia Vera (PV) Trial in Japan (P1101 (Ropeginterferon alfa-2b))

      Recruiting
      • Polycythemia Vera (PV)
      • P1101 (Ropeginterferon alfa-2b)
      • Toon-shi, Ehime, Japan
      • +5 more
      Jun 13, 2022

      Primary Myelofibrosis, Post-Polycythemia Vera, Post-Essential Thrombocytopenia Trial in United States (Panobinostat)

      Terminated
      Has Results
      • Primary Myelofibrosis
      • +2 more
      • Scottsdale, Arizona
      • +8 more
      Jul 9, 2021

      Polycythemia Vera, Essential Thrombocythemia Trial in Worldwide (Momelotinib)

      Terminated
      • Polycythemia Vera
      • Essential Thrombocythemia
      • Scottsdale, Arizona
      • +14 more
      Apr 14, 2020

      Myelofibrosis Trial in Worldwide (Ruxolitinib)

      Completed
      Has Results
      • Myelofibrosis
      • Winter Park, Florida
      • +17 more
      Jan 10, 2022

      Essential Thrombocythemia, Primary Myelofibrosis, Fibrotic Stage, Primary Myelofibrosis, Prefibrotic Stage Trial in Doha

      Terminated
      • Essential Thrombocythemia
      • +3 more
      • Diagnostic (18F-FLT PET/CT)
      • Doha, Qatar
        National Center for Cancer Care & Research (NCCCR)
      Aug 10, 2020

      Pediatric Disease Registry in Essential Thrombocythaemia (ET)

      Completed
      • Essential Thrombocythemia (ET)
        • Olomouc, Czechia
        • +31 more
        Mar 16, 2021

        Myelofibrosis, Polycythemia Vera, Thrombocythemia Trial in Worldwide (itacitinib)

        Active, not recruiting
        • Myelofibrosis
        • +2 more
        • New Orleans, Louisiana
        • +20 more
        Aug 25, 2022

        Polycythemia Vera (PV), Essential Thrombocythemia (ET) Trial in Germany (Ruxolitinib, BAT)

        Active, not recruiting
        • Polycythemia Vera (PV)
        • Essential Thrombocythemia (ET)
        • Mannheim, Baden-Württemberg, Germany
        • +23 more
        Oct 6, 2020